A study led by researchers at Children’s Hospital of Philadelphia (CHOP) demonstrates a new method of using decellularized cartilage with patient-specific cells to help enlarge pediatric airways narrowed as a result of severe subglottic stenosis.
Now, a vibrating pill could help doctors determine whether a patient with anorexia nervosa may have a higher risk of relapse, according to a new study by UCLA Health.
A new University of Otago—Ōtākou Whakaihu Waka-led study has put its own spin on Pavlov’s dog experiment, shining a light on how our brain learns new things. The study, “The superior colliculus gates dopamine responses to conditioned stimuli in visual classical conditioning” is published in Nature
A team has identified an experimental molecule capable of “reprogramming” the brain’s immune cells to restore part of their protective function against Alzheimer’s disease. The study, published in the journal Cell Death and Disease, shows that the compound, called OLE, helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicity.
The AMDI™ Mini Respiratory Panel delivers RT-PCR results in under 10 minutes, enabling clinical action in the Time of Care™
Oculogica announced earlier this month that it won FDA 510(k) clearance for the SNAP concussion test.
Distalmotion announced today that it received FDA 510(k) clearance for its Dexter surgical robot in a range of gynecology procedures.
Often called “the window to the soul,” the eyes may also offer clues about something less poetic but just as important: the health of the brain. A new study of tens of thousands of patients has revealed that cheap, simple and common photographs of the retina at the back of the eye can accurately predict many of the most common risk factors associated with developing Alzheimer’s disease.
Embolization of abnormal blood vessels using rapidly resorbable gelatin-based microspheres is safe and provides significant, lasting pain relief and functional improvement for patients with osteoarthritis-related knee pain, according to a new study published in Radiology.
Researchers at MUSC Hollings Cancer Center, led by Noel Warfel, Ph.D. revealed a previously unknown mechanism that helps prostate cancer cells evade treatment and points to a potential strategy for overcoming that resistance.